Clinical Application Evaluation and Standard，Reasonable Use of Fat Emulsion，Amino Acids （17） and Glucose （11%） Injection

Xiuhua WANG; Zeran HE; Zhihong LI; Huiling WANG; Hongyan SU

doi:10.12259/j.issn.2095-610X.S20230318

Volume 44 Issue 3

Mar. 2023

Turn off MathJax

Article Contents

Abstract

References

Relative Articles

Article Navigation > Journal of Kunming Medical University > 2023 > 44(3): 138-142

Xiang Xi , Li Wan Bi , Zhang Xian , Liu Hua , Wang Yu Ming , Yang Cai , Bai Yun Xia . Correlation between Vitamin D Receptor (VDR) Gene ApaⅠ, BsmⅠ Single Nucleotide Polymorphism and Diabetic Kidney Disease in Type 2 Diabetic Patients[J]. Journal of Kunming Medical University, 2017, 38(08): 79-85.

Citation:

Xiuhua WANG, Zeran HE, Zhihong LI, Huiling WANG, Hongyan SU. Clinical Application Evaluation and Standard，Reasonable Use of Fat Emulsion，Amino Acids （17） and Glucose （11%） Injection[J]. Journal of Kunming Medical University, 2023, 44(3): 138-142. doi: 10.12259/j.issn.2095-610X.S20230318

Citation:

PDF( 782 KB)

Clinical Application Evaluation and Standard，Reasonable Use of Fat Emulsion，Amino Acids （17） and Glucose （11%） Injection

doi: 10.12259/j.issn.2095-610X.S20230318

Dept. of Clinical Pharmacy，Lincang People’s Hospital，Lincang Yunnan 677099，China

Received Date: 2022-09-26
Available Online: 2023-03-02
Publish Date: 2023-03-25

Abstract

Abstract

Objective To evaluate the clinical application of fat emulsion amino acid （17） glucose （11%） injection （trade name: Calvin） to improve the standardization and rationality of it’s clinical application. Methods Using the hospital information system （Hiss） , 30 medical records were randomly selected every quarter with 360 medical records from October 2019 to September 2022. Reference basis for review, such as “the instructions of drugs”, “ building guide ”, “Standard of parenteral nutrition therapy in Lincang People’s Hospital”, and “Evaluation criteria for special prescriptions of Fat Emulsion, Amino Acids （17） and Glucose （11% ） Injection （for trial implementation）”. Comments on the content: whether the indication of drug use is appropriate, whether the dosage of drug usage is appropriate, whether the drug are suitable, whether incompatibility of drugs is contraindicated, the right or wrong deployment sequence. Results Of the 360 medical records collected, 62 were unreasonable in the use of Calvin, with an overall unreasonable rate of 17.2% . The rates of inappropriate use of Calvin were 16.7% , 13.3% , 13.3% , 23.3% , 23.3% , 26.7% , 26.7% , 26.7% , 10.0% , 13.3% , 10.0% and 3.3% respectively. Conclusion According to the review, there are some problems in Cavan’s clinical use, such as not strictly grasping the indication of drug use, many kinds of drugs added to Calvin, unsuitable added drugs, unsuitable added drug dosage forms and excessive dosage, contraindication in compatibility, and wrong order of Calvin’s dispensing. It is suggested that pharmacists should increase the strength, intensity and depth of the evaluation of clinical use of Calvin so as to improve the standardization and rationality of its use.
- Calvin,
- Rationality evaluation,
- Clinical application,
- Pharmacist recommendations.

FullText(HTML)

References(23)

References

[1]	中华医学会肠外肠内营养学分会药学协作组. 规范肠外营养液配制[J]. 协和医学杂志, 2018, 9（4）: 320-331.
[2]	广东省药学会. 肠外营养临床药学共识(第2版)[J]. 今日药学,2017,27(5):289-303.
[3]	国家卫生健康委. 国家卫生健康委办公厅关于印发静脉用药调配中心建设与管理指南（试行）[EB/OL]. （2021-12-10）[2022-05-26]. http://www.nhc.gov.cn/.
[4]	王仲萍,徐萌欣. 静脉用药集中调配中心临床药师医嘱前置审核工作模式的探索[J]. 黑龙江医学,2020,44(2):226-228.
[5]	陈春莲. 静脉用药调配中心对不合理用药医嘱干预效果观察[J]. 海峡药学,2020,32(11):215-217.
[6]	杨雄堡,李召红,谭磊. 临床药师医嘱审核在肠外营养液调配中的临床价值分析[J]. 中国实用医药,2021,16(31):163-165.
[7]	Allen L V. Remington: the science and practice of Pharmacy[M]. 22nd ed. Philadelphia: Pharmaceutical Press, 2014: 2267-2268.
[8]	兰天,吴洪文,杨志杰. 我院2017年第3季度全肠外营养液处方分析[J]. 临床合理用药,2019,12(4A):9-12.
[9]	宋雪敏,盛香玲,彭婕. 我院全肠外营养医嘱审核综合分析[J]. 药学与临床研究,2020,28(1):56-59,62.
[10]	杜珮瑜,郑雪花,李晓冰. 不同浓度K⁺对肠外营养液稳定性的影响研究[J]. 中国药房,2018,29(15):2037-2040.
[11]	文庆燕,吉雪珂. 某医院肠外营养液的临床应用现状分析[J]. 中国药物与临床,2019,19(11):1890-1891.
[12]	张俊鹏,张宝婵,杨威. 某院静脉药物调配中心肠外营养液835份不合理处方分析[J]. 中国药物经济学,2020,15(4):27-30.
[13]	杨阳,顾海娟,陆海敏. 肿瘤专科医院脂肪乳氨基酸(17) 葡萄糖( 11% ) 注射液临床使用分析[J]. 海峡药学,2019,31(10):126-128.
[14]	王亚军,刘莉. 某院2018~2019年全肠外营养液处方分析[J]. 中国合理用药探索,2021,18(9):44-45.
[15]	钟文辉,何春明,李琳. PIVAS肠外营养液配置不合理医嘱分析及其干预措施探讨[J]. 临床合理用药,2021,14(12):148-150.
[16]	范静,李相成,李飞. 注射用脂溶性维生素(Ⅱ)/水溶性维生素与常用电解质配伍的稳定性考察[J]. 中国药房,2017,28(11):1478-1482. doi: 10.6039/j.issn.1001-0408.2017.11.11
[17]	严承宗,陈秋南. 普外科手术患者肠外营养液处方分析与营养液的稳定性研究[J]. 中国现代药物应用,2022,16(14):170-173.
[18]	古艳婷,李悦,王艳春. 临床药师对静脉用药调配中心补充性肠外营养不合理医嘱审核的实践与分析[J]. 中国医院用药评价与分析,2020,20(8):1005-1008.
[19]	闵娜,盛向远,江媛璎,等. PIVAS用药闭环管理模式下全肠外营养液合理用药改进效果分析[J]. 当代医学,2020,26(12):3.
[20]	邢瑞英,常妞平,晋庆霞. 探讨静脉用药调配中心肠外营养液规范化配制及其稳定性影响观察[J]. 医药前沿,2020,10(27):236-237.
[21]	朱磊. 肠外营养液规范化配制及稳定性的应用及研究[J]. 北方药学,2021,18(1):121-122. doi: 10.3969/j.issn.1672-8351.2021.01.054
[22]	林婷婷,骆琼莲,吴毓婷. 我院肠外营养液配置的思考[J]. 海峡药学,2019,3(9):223-224.
[23]	陈满满,王莉,姬静. 精益管理在全合一营养液配制环节的应用[J]. 现代医院管理,2020,18(6):43-46.

Relative Articles(20)

Relative Articles

[1]	Menghuan LI, Li AI, Yongxia LI. Single-cell RNA Sequencing: A New Perspective in the Study of Chronic Obstructive Pulmonary Disease. Journal of Kunming Medical University, 2025, 46(3): 1-6.
[2]	Rui CUN, Meiling CHEN. Efficacy and Clinical Application of Flunarizine Combined with Ginkgo damo in Treatment of Senile Vertigo. Journal of Kunming Medical University, 2022, 43(7): 116-120. doi: 10.12259/j.issn.2095-610X.S20220703
[3]	Hong-yan JIANG, Rui-lin ZHANG, Yan CAO, Hai-ying WU, Ping LI. Application Prospect of Mannabidiol in Medicine. Journal of Kunming Medical University, 2021, 42(2): 147-152. doi: 10.12259/j.issn.2095-610X.S20210208
[4]	Yang Shu Di , Zhong Yu Li , Liu Ling , Tian Xin . . Journal of Kunming Medical University, 2020, 41(05): 1-6.
[5]	Yang Yue, Tao Jian Ping . . Journal of Kunming Medical University, 2019, 40(12): 135-139.
[6]	Wang Xiu Hua , Yang Zhong Ming , Yang Chao , Zhang Guang Yun , Ren Dong Wei , Wang Xue Chang . Evaluation of the Clinical Application of Antineoplastic Drugs in Lincang People's Hospital. Journal of Kunming Medical University, 2017, 38(07): 88-92.
[7]	Zhou Ying . Clinical Application of the Next-generation Sequencing Technology. Journal of Kunming Medical University,
[8]	Wang Dong Mei . . Journal of Kunming Medical University,
[9]	Li Jian Gang . . Journal of Kunming Medical University,
[10]	Wang Can Zhi . . Journal of Kunming Medical University,
[11]	Meng Li Hong . . Journal of Kunming Medical University,
[12]	Li Jian Gang . . Journal of Kunming Medical University,
[13]	Du Xiong . . Journal of Kunming Medical University,
[14]	Zhang Hong Jiang . . Journal of Kunming Medical University,
[15]	Song Chao . . Journal of Kunming Medical University,
[16]	. Clinical Experience of Acanthopanax Senticosus Injection in the Treatment of 60 Cases of Insomnia. Journal of Kunming Medical University,
[17]	. Clinical Effect of Xuebijing Injection on Pro/Anti-inflammatory Balance in Sepsis Patients. Journal of Kunming Medical University,
[18]	. Clinical Application of Capsule Endoscopy in Gastrointestinal Diseases. Journal of Kunming Medical University,
[19]	. . Journal of Kunming Medical University,
[20]	Sun Jie . . Journal of Kunming Medical University,

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	祝艺娟，罗倩倩，方海顺，杜碧莹. 超高效液相色谱法测定脂肪乳氨基酸（17）葡萄糖（11%）注射液中有关物质5-羟色氨酸. 中国处方药. 2025(01): 35-37 .
2.	屈伟，张颖，曹凯. 某院肠外营养多腔袋临床应用现状调查. 山西医药杂志. 2025(01): 46-49 .
3.	杨培培，张丽雯，程钢，黄赵刚. 脂肪乳氨基酸（17）葡萄糖（11%）注射液稳定性研究. 中国药业. 2024(02): 60-62 .
4.	蒋红娟，王璐，夏军龙. 7种单抗注射液类新药配伍后pH值及外观稳定性研究. 婚育与健康. 2024(01): 76-78 .
5.	宋德红. 专项处方点评模式对临床合理用药的影响. 中国社区医师. 2024(04): 163-165 .
6.	黄娜，肖慧芳，李明伟. 临床药师干预第二批重点监控药品应用的实践分析. 中国药物滥用防治杂志. 2024(11): 2030-2031+2043 .